Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

NGOs Urge EU Ministers To Resist 'Industry Pressure' and Reform RnD Model, Raise Regulatory Standards

This article was originally published in SRA

Executive Summary

A group of 25 civil society bodies and NGOs have called on EU member states to resist what they describe as 'pressure from the pharmaceutical industry to eliminate critical elements of proposed EU Council Conclusions' that are intended to improve the balance between intellectual property measures designed to encourage innovation and the need to ensure patients have access to affordable medicines1.

Advertisement

Related Content

MEPs Slate EU Industry Practices In Report On Barriers To Medicines Access
Advertisement
UsernamePublicRestriction

Register